Orungan, Macy Kim .

HRN: 25-05-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2024
CEFUROXIME 750MG (VIAL)
10/16/2024
10/23/2024
IV
Q8
Q8
Uti
Rejected 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines